161 related articles for article (PubMed ID: 10998713)
1. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache.
Porta M
Curr Rev Pain; 2000; 4(1):31-5. PubMed ID: 10998713
[TBL] [Abstract][Full Text] [Related]
2. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
Porta M
Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
[TBL] [Abstract][Full Text] [Related]
3. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.
Schmitt WJ; Slowey E; Fravi N; Weber S; Burgunder JM
Headache; 2001; 41(7):658-64. PubMed ID: 11554953
[TBL] [Abstract][Full Text] [Related]
4. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study.
Rollnik JD; Tanneberger O; Schubert M; Schneider U; Dengler R
Headache; 2000 Apr; 40(4):300-5. PubMed ID: 10759934
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.
Wheeler AH
Headache; 1998 Jun; 38(6):468-71. PubMed ID: 9664753
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin (DYSPORT) in tension-type headaches.
Rollnik JD; Dengler R
Acta Neurochir Suppl; 2002; 79():123-6. PubMed ID: 11974977
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type-A therapy in cluster headache: an open study.
Sostak P; Krause P; Förderreuther S; Reinisch V; Straube A
J Headache Pain; 2007 Sep; 8(4):236-41. PubMed ID: 17901920
[TBL] [Abstract][Full Text] [Related]
9. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
10. Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study.
Straube A; Empl M; Ceballos-Baumann A; Tölle T; Stefenelli U; Pfaffenrath V;
Eur J Neurol; 2008 Mar; 15(3):205-13. PubMed ID: 18290842
[TBL] [Abstract][Full Text] [Related]
11. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches?
Rollnik JD; Karst M; Fink M; Dengler R
Headache; 2001; 41(10):985-9. PubMed ID: 11903527
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
Freund B; Rao A
Pain Pract; 2019 Jun; 19(5):541-551. PubMed ID: 30742360
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin: could it be an effective treatment for chronic tension-type headache?
Hamdy SM; Samir H; El-Sayed M; Adel N; Hasan R
J Headache Pain; 2009 Feb; 10(1):27-34. PubMed ID: 19030947
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
[TBL] [Abstract][Full Text] [Related]
16. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
17. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A.
Freund BJ; Schwartz M
Headache; 2002; 42(10):1033-7. PubMed ID: 12453036
[TBL] [Abstract][Full Text] [Related]
18. Comparison Between Steroid and 2 Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia: A Randomized, Double-Blind, Active Drug-Controlled Pilot Study.
Guo YH; Kuan TS; Chen KL; Lien WC; Hsieh PC; Hsieh IC; Chiu SH; Lin YC
Arch Phys Med Rehabil; 2017 Jan; 98(1):36-42. PubMed ID: 27666156
[TBL] [Abstract][Full Text] [Related]
19. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
Sherif H; Khalil M; Omar R
Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
